Tscan Therapeutics, Inc. · NASDAQ:TCRX

Lynx1 Capital Management LP reported a 10.90% stake in Tscan Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 14, 2025

Lynx1 Capital Management LP reported a 10.90% stake in Tscan Therapeutics, Inc., 5,357,347 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).

Stake
10.90%
Shares
5,357,347
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Lynx1 Capital Management LP10.90%5,357,347
Weston Nichols10.90%5,357,347

Source

View original at SEC

Related